Department of Clinical and Molecular Medicine, La Sapienza University, Rome, Italy.
Atherosclerosis. 2011 Sep;218(1):194-9. doi: 10.1016/j.atherosclerosis.2011.04.035. Epub 2011 May 6.
The chronic kidney disease (CKD)-Epidemiology Collaboration (EPI) equation was shown to be more accurate than the Modification of Diet in Renal Disease (MDRD) Study formula for estimating glomerular filtration rate (GFR) in the general population. This study was aimed at assessing cardiovascular disease (CVD) burden associated with CKD in type 2 diabetes, using these two GFR estimating formulas for CKD definition.
This cohort study examined 15,773 Caucasian patients with type 2 diabetes participating in the Renal Insufficiency And Cardiovascular Events Italian Multicenter Study (NCT00715481) and attending the baseline visit in 19 diabetes clinics in years 2007-2008. Serum creatinine was assessed by the modified Jaffe method. Albuminuria was measured by immunonephelometry or immunoturbidimetry. CKD was defined as an estimated GFR (eGFR) <60 mL/min/1.73 m(2) and/or micro/macroalbuminuria.
Prevalence of impaired eGFR and CKD decreased from 18.7% to 17.2% (P=0.0012) and from 37.5% to 36.3% (P=0.077), respectively, with the CKD-EPI, as compared with the MDRD Study equation. Subjects with impaired eGFR or CKD with the MDRD Study equation only showed lower CVD prevalence rates and coronary heart disease risk scores, mainly driven by prevailing female sex, younger age and shorter diabetes duration, as compared with those with both formulas, whereas opposite figures were observed in patients falling into these categories with the CKD-EPI equation only.
Estimating GFR in patients with type 2 diabetes using the CKD-EPI equation provides a better definition of CVD burden associated with CKD not only in individuals reclassified upward, but also in those reclassified downward.
与肾脏病膳食改良研究(MDRD)公式相比,慢性肾脏病(CKD)-流行病学协作(EPI)方程在一般人群中估算肾小球滤过率(GFR)更为准确。本研究旨在使用这两种 GFR 估算公式来定义 CKD,评估 2 型糖尿病患者 CKD 相关的心血管疾病(CVD)负担。
本队列研究共纳入了 15773 例参加意大利肾脏不足和心血管事件多中心研究(Renal Insufficiency And Cardiovascular Events Italian Multicenter Study,NCT00715481)的 2 型糖尿病白种人患者,这些患者于 2007-2008 年在 19 个糖尿病诊所接受了基线检查。血清肌酐采用改良的 Jaffe 法检测。白蛋白尿采用免疫比浊法或免疫散射比浊法测量。CKD 的定义为估算肾小球滤过率(eGFR)<60 mL/min/1.73 m(2)和/或微量白蛋白尿/大量白蛋白尿。
与 MDRD 研究方程相比,用 CKD-EPI 方程定义的 CKD 患者中,估算肾小球滤过率(eGFR)受损和 CKD 的患病率分别从 18.7%降至 17.2%(P=0.0012)和从 37.5%降至 36.3%(P=0.077)。仅用 MDRD 研究方程定义的 CKD 患者的 eGFR 受损或 CKD 患者的 CVD 患病率和冠心病风险评分较低,这主要归因于女性、年龄较小和糖尿病病程较短,而在仅用 CKD-EPI 方程定义的患者中则观察到相反的结果。
在 2 型糖尿病患者中使用 CKD-EPI 方程估算 GFR,不仅能更好地定义 CKD 相关 CVD 负担,而且对那些向上重新分类和向下重新分类的患者都能提供更好的定义。